Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Isis reacquires full rights to ISIS-2302 and negotiates with commercialization partners

Sep. 7, 1999

Nabi hepatitis C drug shows promise in chimpanzee study

Sep. 6, 1999

Shenyang Pharmaceutical University synthesizes new antiulcer benzimidazoles

Sep. 3, 1999

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Lotronex NDA gets priority review from FDA

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Glaxo Wellcome proposes to discontinue Wellferon

Aug. 31, 1999

News from ACS: hepatitis C viral protease inhibitor BILN-303-SE

Aug. 30, 1999

5-HT4 receptor ligands studied extensively at Roche Bioscience

Aug. 30, 1999

Incara subsidiary licenses rights to liver progenitor cell technology

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...